Mitochondrial damage-associated molecular patterns and vascular function

European Heart Journal

Volumn 35, Issue 18, 2014, Pages 1172-1177

  Wenceslau, Camilla Ferreira ^a   McCarthy, Cameron G ^a   Szasz, Theodora ^a   Spitler, Kathryn ^a   Goulopoulou, Styliani ^a   Webb, R Clinton ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Cardiovascular disease; Damage associated molecular patterns; Immune system; Mitochondria; Vascular function

Indexed keywords

FORMYLMETHIONYLLEUCYLPHENYLALANINE; MICRORNA; MITOCHONDRIA DAMAGE ASSOCIATED MOLECULAR PATTERN; MITOCHONDRIAL DNA; PATTERN RECOGNITION RECEPTOR; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; CYTOKINE; OLIGOPEPTIDE;

BLOOD VESSEL INJURY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR SYSTEM; CELL DEATH; CELL STRESS; CIRCULATION; HEART MITOCHONDRION; HUMAN; IMMUNE SYSTEM; IMMUNITY; IMMUNOREACTIVITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; VASCULITIS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; MITOCHONDRION; PHYSIOLOGY;

CARDIOVASCULAR DISEASES; CYTOKINES; DNA, MITOCHONDRIAL; HUMANS; IMMUNITY, INNATE; MITOCHONDRIA; MITOCHONDRIAL DISEASES; OLIGOPEPTIDES;

EID: 84900299510     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehu047     Document Type: Review

References (54)

1. Sagan L. On the origin of mitosing cells. J Theor Biol 1967;14:255-274.
2. Margulis L, Bermudes D. Symbiosis as a mechanism of evolution: status of cell symbiosis theory. Symbiosis 1985;1:101-124.
3. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol 1994;12: 991-1045.
4. Krysko DV, Agostinis P, Krysko O, Garg AD, Bachert C, Lambrecht BN, Vandenabeele P. Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation. Trends Immunol 2011;32:157-164.
5. Wenceslau CF, McCarthy CG, Goulopoulou S, Szasz T, NeSmith EG, Webb RC. Mitochondrial-derived N-formyl peptides: novel links between trauma, vascular collapse and sepsis. Med Hypotheses 2013;81:532-535.
6. Goulopoulou S, Matsumoto T, Bomfim GF, Webb RC. Toll-like receptor 9 activation: a novel mechanism linking placenta-derived mitochondrial DNA and vascular dysfunction in pre-eclampsia. Clin Sci 2012;123:429-435.
7. Alberts B. Molecular Biology of the Cell. 5th edn. New York: Garland Science; 2008.
8. Addabbo F, Montagnani M, Goligorsky MS. Mitochondria and reactive oxygen species. Hypertension 2009;53:885-892.
9. Giorgio M, Migliaccio E, Orsini F, Paolucci D, Moroni M, Contursi C, Pelliccia G, Luzi L, Minucci S, Marcaccio M, Pinton P, Rizzuto R, Bernardi P, Paolucci F, Pelicci PG. Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell 2005;122:221-233.
10. Wang C, Youle RJ. The role of mitochondria in apoptosis. Annu Rev Genet 2009;43: 95-118.
11. Rowland AA, Voeltz GK. Endoplasmic reticulum-mitochondria contacts: function of the junction. Nat Rev Mol Cell Biol 2012;13:607-625.
12. Rizzuto R, DeStefani D, Raffaello A, Mammucari C. Mitochondriaassensors and regulators of calcium signalling. Nat Rev Mol Cell Biol 2012;13:566-578.
13. Rather LJ. Disturbance of function (functio laesa): the legendary fifth cardinal sign of inflammation, added by Galen to the four cardinal signs of Celsus. Bull N Y Acad Med 1971;47:303-322.
14. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994;76:301-314.
15. Mann DL. The emerging role of innate immunity in the heart and vascular system: for whom the cell tolls. Circ Res 2011;108:1133-1145.
16. Matzinger P. The danger model:A renewed sense of self. Science 2002;296:301-305.
17. Taanman JW. The mitochondrial genome: structure, transcription, translation and replication. Biochim Biophys Acta 1999;1410:103-123.
18. Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, Brohi K, Itagaki K, Hauser CJ. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 2010;464:104-107.
19. Oka T, Hikoso S, Yamaguchi O, Taneike M, Takeda T, Tamai T, Oyabu J, Murakawa T, Nakayama H, Nishida K, Akira S, Yamamoto A, Komuro I, Otsu K. Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure. Nature 2012;485:251-255.
20. Lacobazzi V, Castegna A, Infantino V, Andria G. Mitochondrial DNA methylationasa next-generation biomarker and diagnostic tool. Mol Genet Metab 2013;110:25-34.
21. Kaufman DBA, Durisic N, Mativetsky JM, Costantino S, Hancock MA, Grutter P, Shoubridge EA. The mitochondrial transcription factor TFAM coordinates the assembly of multiple DNA molecules into nucleoid-like structures. Mol Biol Cell 2007;18:3225-3236.
22. Yu E, Mercer J, Bennett M. Mitochondria in vascular disease. Cardiovas Res 2012;95: 173-182.
23. Chan NC, Chan DC. Parkin uses the UPS to ship off dysfunctional mitochondria. Autophagy 2011;7:771-772.
24. Shieh SY, Ahn J, Tamai K, Taya Y, Prives C. The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. Genes Dev 2000;14:289-300.
25. Kukat A, Edgar D, Bratic I, Maiti P, Trifunovic A. Random mtDNA mutations modulate proliferation capacity in mouse embryonic fibroblasts. Biochem Biophys Res Commun 2011;409:394-399.
26. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H, Takeda K, Akira S. A toll-like receptor recognizes bacterial DNA. Nature 2000;408:740-745.
27. Ding Z, Liu S, Wang X, Khaidakov M, Dai Y, Mehta JL. Oxidant stressinmitochondrial DNA damage, autophagy and inflammation in atherosclerosis. Sci Rep 2013;3:1077.
28. Erridge C, Burdess A, Jackson AJ, Murray C, Riggio M, Lappin D, Milligan S, Spickett CM, Webb DJ. Vascular cell responsiveness to Toll-like receptor ligands in carotid atheroma. Eur J Clin Invest 2008;38:713-720.
29. Latz E, Schoenemeyer A, Visintin A, Fitzgerald KA, Monks BG, Knetter CF, Lien E, Nilsen NJ, Espevik T, Golenbock DT. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat Immunol 2004;5:190-198.
30. Veiko NN, Konorova IL, Neverova ME, Didelina OV, Mkrtumova NA, Ershova ES, Kon'kona MS, Postnov AY. The effect ofCpG-rich DNA fragments on the development of hypertension on spontaneously hypertensive rats. Biomed Chem 2010;4: 269-278.
31. Colleoni F, Lattuada D, Garretto A, Massari M, Mando C, Somigliana E, Cetin I. Maternal blood mitochondrial DNA content during normal and intrauterine growth restricted (IUGR) pregnancy. Am J Obstet Gynecol 2010;203:365.
32. Le Y, Murphy PM, Wang JM. Formyl-peptide receptors revisited. Trends Immunol 2002;23:541-548.
33. Hauser CJ, Sursal T, Rodriguez EK, Appleton PT, Zhang Q, Itagaki K. Mitochondrial DAMPs fromfemoralreamings activate neutrophils via formyl peptide receptorsand P44/42 MAP kinase. J Orthop Trauma 2010;24:534-538.
34. Bode SM, Kuhn M, Förstermann U. Chemotactic peptide FMLP contracts human coronary arteries via cyclooxygenase products. Am J Physiol 1990;258:H848-H853.
35. Keitoku M, Kohzuki M, Katoh H, Funakoshi M, Suzuki S, Takeuchi M, Karibe A, Horiguchi S, Watanabe J, Satoh S, Nose M, Abe K, Okayama H, Shirato K. FMLP actions and its binding sites in isolated human coronary arteries. J Mol Cell Cardiol 1997;29:881-894.
36. Laplante C, Tremblay B, Marceau F. Relaxant effect of N-formyl-methionyl-leucyl-phenylalanine on rabbit vascular strips. J Pharmacol Exp Ther 1989;248:774-780.
37. Rabiet MJ, Huet E, Boulay F. Human mitochondria-derived N-formylated peptides are novel agonists equally active on FPRand FPRL1, while Listeria monocytogenes-derived peptides preferentially activate FPR. EurJ Immunol 2005;35:2486-2495.
38. Tuominen A, Miller YI, Hansen LF, Kesaniemi YA, Witztum JL, Horkko S. A natural antibody to oxidized cardiolipin binds to oxidized low-density lipoprotein, apoptotic cells, and atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2006;26:2096-2102.
39. Sherer Y, Gerli R, Gilburd B, Bartoloni Bocci E, Vaudo G, Mannarino E, Shoenfeld Y. Thickened carotid artery intima-media in rheumatoid arthritis is associated with elevated anticardiolipin antibodies. Lupus 2007;16:259-264.
40. Gorini S, Gatta L, Pontecorvo L, Vitiello L, la Sala A. Regulation of innate immunity by extracellular nucleotides. Am J Blood Res 2013;3:14-28.
41. Ferrari D, Chiozzi P, Falzoni S, DalSusino M, Melchiorri L, Baricordi OR, Di Virgilio F. Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages. J Immunol 1997;159:1451-1458.
42. McDonald B, Pittman K, Menezes GB, Hirota SA, Slaba I, Waterhouse CC, Beck PL, Muruve DA, Kubes P. Intravascular danger signals guide neutrophils to sites of sterile inflammation. Science 2010;330:362-366.
43. Mariathasan S, Newton K, Monack DM, Vucic D, French DM, Lee WP, Roose-Girma M, Erickson S, Dixit VM. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 2004;430:213-218.
44. Seiffert K, Ding W, Wagner JA, Granstein RD.ATPgammaS enhances the production of inflammatory mediators by a human dermal endothelial cell line via purinergic receptor signaling. J Invest Dermatol 2006;126:1017-1027.
45. Chiao CW, Tostes RC, Webb RC. P2X7 receptor activation amplifies lipopolysaccharide-induced vascular hyporeactivity via interleukin-1 beta release. J Pharmacol Exp Ther 2008;326:864-870.
46. Julian MW, Shao G, Bao S, Knoell DL, Papenfuss TL, VanGundy ZC, Crouser ED. Mitochondrial transcription factor A serves as a danger signal by augmenting plasma-cytoid dendritic cell responses to DNA.J Immunol 2012;189:433-443.
47. Chaung WW, Wu R, Ji Y, Dong W, Wang P. Mitochondrial transcription factor A is a proinflammatory mediator in hemorrhagic shock. Int J Mol Med 2012;30:199-203.
48. Adachi N, Hirota M, Hamaguchi M, Okamoto K, Watanabe K, Endo F. Serum cytochrome c level as a prognostic indicator in patients with systemic inflammatory response syndrome. Clin Chim Acta 2004;342:127-136.
49. Hossen N, Kajimoto K, Akita H, Hyodo M, Ishitsuka T, Harashima H. Therapeutic assessment of cytochrome c for the prevention of obesity through endothelial cell-targeted nanoparticulate system. Mol Ther J Am Soc Gene Ther 2013;21:533-541.
50. Chen K, Rajewsky N. The evolution of gene regulation by transcription factors and microRNAs. Nat Rev Genet 2007;8:93-103.
51. Chen X, Liang H, Zhang J, Zen K, Zhang CY. microRNAs are ligands of Toll-like receptors. RNA 2013;19:737-739.
52. Fabbri M, Paone A, Calore F, Galli R, Gaudio E, Santhanam R, Lovat F, Fadda P, Mao C, Nuovo GJ, Zanesi N, Crawford M, Ozer GH, Wernicke D, Alder H, Caligiuri MA, Nana-Sinkam P, Perrotti D, Croce CM. MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proc Natl Acad Sci 2012;109:E2110-E2116
53. Barrey E, Saint-Auret G, Bonnamy B, Damas D, Boyer O, Gidrol X. Pre-microRNA and mature microRNA in human mitochondria. PLoS ONE 2011;6:e20220.
54. Liu X, Cheng Y, Zhang S, Lin Y, Yang J, Zhang C. A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ Res 2009;104:476-487.